1.
Porto WF, Irazazabal L, Alves ESF, et al. In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. Nat Commun. 2018;9(1):1490. doi:10.1038/s41467-018-03746-3.
1.
Feng S, Kasahara C, Rickles RJ, Schreiber SL. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc Natl Acad Sci U S A. 1995;92(26):12408-15.
1.
Ferrer M, Kapoor TM, Strassmaier T, et al. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol. 1999;6(10):953-60. doi:10.1038/13324.
1.
Williams DR, Nag PP, Zorn N. Strategies for the synthesis of the novel antitumor agent peloruside A. Curr Opin Drug Discov Devel. 2008;11(2):251-71.
1.
Lyons SM, Fay MM, Ivanov P. The role of RNA modifications in the regulation of tRNA cleavage. FEBS Lett. 2018;592(17):2828-2844. doi:10.1002/1873-3468.13205.
1.
Maurer AC, Pacouret S, Diaz AKC, Blake J, Andres-Mateos E, Vandenberghe LH. The Assembly-Activating Protein Promotes Stability and Interactions between AAV’s Viral Proteins to Nucleate Capsid Assembly. Cell Rep. 2018;23(6):1817-1830. doi:10.1016/j.celrep.2018.04.026.
1.
Bowers AA, Greshock TJ, West N, et al. Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole. J Am Chem Soc. 2009;131(8):2900-5. doi:10.1021/ja807772w.
1.
Martinez EJ, Owa T, Schreiber SL, Corey EJ. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. Proc Natl Acad Sci U S A. 1999;96(7):3496-501.
1.
Marsich E, Zuccato P, Rizzi S, Vetere A, Tonin E, Paoletti S. Helicobacter pylori expresses an autolytic enzyme: gene identification, cloning, and theoretical protein structure. J Bacteriol. 2002;184(22):6270-9.
1.
Nguyen NX, Armache J-P, Lee C, et al. Cryo-EM structure of a fungal mitochondrial calcium uniporter. Nature. 2018;559(7715):570-574. doi:10.1038/s41586-018-0333-6.